Cyrtominetin

Overview

Cyrtominetin is a RANKL inhibitor with favorable ADMET properties. Cyrtominetin competitively blocks the binding of RANKL-RANK and increases the compactness of RANKL . Cyrtominetin can be used in studies related to osteoporosis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Mineral Metabolism | Products > Disease Areas > Osteoporosis | Products > Signaling Pathways > NF-κB | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > RANKL/RANK

Product Information

• Catalog No.: HY-106884
• CAS No.: 519-55-1
• Molecular Formula: C17H16O6
• Molecular Weight: 316.31
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source